AEON (AEON Biopharma) Buyback Yield %: -9.74 (As of Jul. 03, 2026)


AEON AEON Biopharma Inc AEON
10 GF Score
Price $0.72
! 2 Warning Signs
View Full Analysis

What is AEON Biopharma Buyback Yield %?

AEON Biopharma AEON +0.58% 10 Buyback Yield % is -9.74 as of Jul. 03, 2026. GuruFocus rates AEON with a GF Score™ of 10/100. The stock has 2 warning signs investors should review. Among 744 Biotechnology companies, AEON Biopharma ranks worse than 51.61% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

AEON Biopharma's current buyback yield was -9.74%.

AEON Biopharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for AEON Biopharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AEON Biopharma Buyback Yield % Chart

AEON Biopharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.68 -139.03

AEON Biopharma Quarterly Data
Dec19 Dec20 Jun21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -300.39 -210.18 -196.64 -139.03 -7.35

AEON vs ZIVO, CVM, ATOS: Buyback Yield % Comparison

For the Biotechnology subindustry, AEON Biopharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEON Biopharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEON Biopharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where AEON Biopharma's Buyback Yield % falls into.


AEON
10GF Score
AEON Biopharma Inc AEON
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AEON Biopharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

AEON Biopharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 18.514) / 13.3166
=-139.03%

AEON Biopharma's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1.833) / 24.923455
=-7.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -9.74 mean?
AEON Biopharma (AEON) has a Buyback Yield % of -9.74 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on AEON Biopharma and its competitors. According to the industry distribution chart, AEON Biopharma ranks #384 out of 744 companies in the Biotechnology industry, placing it in the top 51.6%.
Is AEON Biopharma's Buyback Yield % too high?
AEON Biopharma's current Buyback Yield % is -9.74. Based on the distribution chart, AEON Biopharma ranks #384 out of 744 companies in the Biotechnology industry, which is below the industry midpoint. Overall, AEON Biopharma has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does AEON Biopharma's Buyback Yield % compare to ZIVO and CVM?
According to the Biotechnology industry distribution chart, AEON Biopharma ranks #384 out of 744 companies for Buyback Yield %. This places AEON Biopharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on AEON Biopharma and its competitors. AEON Biopharma's current Buyback Yield % is -9.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AEON Biopharma stock overvalued right now?
AEON Biopharma (AEON) has a current Buyback Yield % of -9.74. The current Buyback Yield % is -9.74. AEON Biopharma's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For AEON Biopharma (AEON), the current Buyback Yield % is -9.74 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AEON Biopharma Business Description

Address 5 Park Plaza, Suite 1750, Irvine, CA, USA, 92614
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
10GF Score

Get the complete analysis for AEON

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72
Price